the healing effect of the prokinetic drug cisapride ( 10 mg q.i.d . ) on esophageal lesions , and its therapeutic control of gastroesophageal reflux symptoms were compared with the effects of the h2-antagonist ranitidine ( 150 mg b.i.d . + placebo b.i.d . ) in a double-blind trial .
C0072916
cisapride
C0017168
gastroesophageal reflux